Diabetes Drugs Flashcards

1
Q

Biguanides mechanism of action

A

Not fully understood, increases peripheral insulin sensitivity by increasing glucose uptake, decreasing hepatic gluconeogenesis and reducing glucose absorption in the gut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Example of biguanides

A

Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Side effects of biguanides

A

Weight loss, reduced microvascular complications, GI upset, lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Contraindications of biguanides

A

Avoid in liver and renal dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Administration of biguanides

A

Start low go slow 500mg-1g BD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanism of action of SUs

A

Displace ADP-Mg2+ at the SUR1subunit closing KATP channels preventing K+ efflux resulting in depolarisation of the B cells in the pancreas which stimulates voltage gated calcium channels resulting in insulin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Examples of SUs

A

Short acting: Gliclazide, tolbutamide

Long acting: Glibenclamide, glipizide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Side effects of SUs

A

Hypoglycaemia, weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Should SUs be taken with or without food

A

WITH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Glinides mechanism of action

A

Binds to benzamide site of the SUR1 subunit, closes the KATP channel preventing K+ efflux resulting in depolarisation and stimulating insulin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Examples of glinides

A

Repaglinide, nateglinide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Side effects of glinides

A

Less likely to cause hypoglycaemia, safer in CKD, weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When should glinides not be used

A

Severe hepatic impairment, breastfeeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DDP4 inhibitors mechanism of action

A

Competitive inhibition of DDP-4 to increase insulin release, decrease glucagon release, delay gastric emptying

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Examples of DDP4 inhibitors

A

Sitagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Side effects of DD4 inhibitors

A

Nausea, watch in renal impairment

17
Q

Incretin analogues mechanism of action

A

GLP-1 receptor analogues stimulating insulin release, decrease glucagon release, delay gastric emptying, resistant to DDP4 breakdown

18
Q

Examples of incretin analogues

A

Liraglutide, exenatide

19
Q

Incretin analogues side effects

A

Weight loss + cardiac benefits, nausea

20
Q

Alpha-glucosidase inhibitors mechanism of action

A

A-glucosidase is a brush border enzyme that breakdown dietary carbs, starch + dissacharides to absorbable glucose, inhibition prevents glucose absorption reducing a large spike in blood glucose after eating

21
Q

Examples of alpha-glucosidase inhibitor

A

Acarbose, miglitol

22
Q

Side effects of alpha-glucosidase inhibitor

A

Flatulence, loose stools, diarrhoea, abode pain, bloating due to colonic bacteria reacting with undigested carbs

23
Q

Thiazolidinediones mechanism of actions

A

PPARgamma agonist that binds to RXR receptor in adipocytes to act as a transcription factor to increase expression of genes that increase insulin release and affect lipid metabolism (decrease fatty acid release from adipose tissue + promotes storage, tissues have to find alternative energy sources so enhances peripheral glucose uptake)

24
Q

Examples of TZDs

A

Pioglitazone

25
Q

Side effects of TZDs

A

Weight gain, fluid retentions (CHF), hepatotoxicity (except for pioglitazone), fractures, risk of DKA, risk of bladder cancer

26
Q

SGLT2 inhibitors mechanism of action

A

Inhibits glucose reabsorption by blocking SLGt2 channel in PCT promoting excretion

27
Q

Examples of SGLT2 inhibitors

A

empagliflozin, canagliflozin, dapaglifloxin

28
Q

Side effects of SGLT2 inhibitors

A

UTIs/thrush, hypotension (water follows glucose), risk of bladder cancer, risk of euglycaemic acidosis, weight loss, cardiac benefits,